
134PMutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors
Wagener-Ryczek, S, Heydt, C, Sueptitz, J, Michels, S, Falk, M, Alidousty, C, Fassunke, J, Tiemann, M, Heukamp, L, Wolf, J, Buettner, R, Merkelbach-Bruse, SVolume:
30
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz063.032
Date:
April, 2019
Fichier:
PDF, 76 KB
english, 2019